Objective: To determine whether the β-lactam allergy delabeling was safe and cost-saving in Primary Care (PC) patients.
Design: We have conducted a retrospective chart review of PC patients with β-lactam allergy label evaluated in our Allergy Unit between 2017 and 2022. SITE: Allergy Department.